EUVIMEDEUVIMED entdecken
Open Access

Metabolomics-Defined Subtypes of Prediabetes and Risk of Cardiovascular-Kidney-Metabolic Outcomes

Fei Chen iD, Yang Zhang iD, Weihao Wang, Ge Li, Jian Zhang, Peiheng Zhang, Jingcui Guo, Wuxiang Xie, Feifei Zhang iD, Ying Gao iD

Diabetes · 2026

DOI: 10.2337/db26-0218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2026. Verfasst von Fei Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Prediabetic State, Metabolomics, Cardiovascular Diseases, Diabetes Mellitus, Type 2. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Young Elite Scientists Sponsorship Program by CAST, the National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital), National High Level Hospital Clinical Research Funding (Youth Clinical Research Project of Peking University First Hospital).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prediabetes is highly prevalent and biologically heterogeneous, yet current glycemic definitions do not adequately capture differences in cardiometabolic and kidney risk. We aimed to identify metabolically defined subtypes of prediabetes using circulating metabolites and to examine their associations with cardiovascular-kidney-metabolic outcomes. We analyzed 24,638 participants with prediabetes from the UK Biobank who had metabolomics data available. Metabolomic biomarkers related to type 2 diabetes, cardiovascular disease, and chronic kidney disease were identified using machine learning–based feature selection methods, and unsupervised clustering was applied to derive metabolic subtypes. Associations between subtypes and cardiometabolic outcomes were evaluated, and interactions between dietary patterns and metabolic subtypes were explored. Mendelian randomization analyses were conducted to investigate potential causal roles of key metabolomic biomarkers. Three metabolically distinct subtypes of prediabetes were identified, representing low-, intermediate-, and high-risk metabolic profiles. These subtypes showed progressively higher risks of developing type 2 diabetes, cardiovascular disease, and chronic kidney disease during follow-up, and the associations between diet quality and disease outcomes differed across subtypes. Several metabolomic biomarkers demonstrated potential causal links with cardiometabolic outcomes. These findings highlight the metabolic heterogeneity of prediabetes and suggest that metabolomics-based subtypes may improve risk stratification and support precision prevention strategies. Article Highlights Previous studies have identified heterogeneity among prediabetes subgroups using clinical characteristics; however, biological and metabolic heterogeneity remains insufficiently captured. This study examined whether data-driven clustering based on metabolomic biomarkers could define distinct prediabetes subtypes with differential type 2 diabetes, cardiovascular disease, and chronic kidney disease risk. Using 16 metabolomic biomarkers, we identify three metabolically distinct clusters showing progressively higher risks of incident type 2 diabetes, cardiovascular disease, and chronic kidney disease. Differential diet-cluster associations across clusters were obtained, and Mendelian randomization supported potential causal roles for several metabolomic biomarkers. Metabolomics-based stratification may improve risk prevention and enable cluster-specific dietary interventions in prediabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prediabetic StateMetabolomicsCardiovascular DiseasesDiabetes Mellitus, Type 2Renal Insufficiency, ChronicHumansBiomarkersFemaleMaleMiddle AgedRisk FactorsAgedMendelian Randomization Analysis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Endocrinology, Peking University First Hospital, Beijing, China.
  • Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Clinical Research Institute, Institute of Advanced Clinical Medicine, Peking University, Beijing, China.
  • Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
  • Center for Digital Health and Artificial Intelligence, Peking University First Hospital, Beijing, China.

ORCID-Profile: Fei Chen, Yang Zhang, Feifei Zhang, Ying Gao

Förderung

  • Young Elite Scientists Sponsorship Program by CAST
  • the National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital)
  • National High Level Hospital Clinical Research Funding (Youth Clinical Research Project of Peking University First Hospital)
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Chen, F., Zhang, Y., Wang, W., Li, G., Zhang, J., Zhang, P., Guo, J., Xie, W., Zhang, F., & Gao, Y. (2026). Metabolomics-Defined Subtypes of Prediabetes and Risk of Cardiovascular-Kidney-Metabolic Outcomes. Diabetes. https://doi.org/10.2337/db26-0218

Vancouver

Chen F, Zhang Y, Wang W, Li G, Zhang J, Zhang P, et al. Metabolomics-Defined Subtypes of Prediabetes and Risk of Cardiovascular-Kidney-Metabolic Outcomes. Diabetes. 2026. doi:10.2337/db26-0218

BibTeX
@article{Chen2026,
  author = {Chen, Fei and Zhang, Yang and Wang, Weihao and Li, Ge and Zhang, Jian and Zhang, Peiheng and Guo, Jingcui and Xie, Wuxiang and Zhang, Feifei and Gao, Ying},
  title = {Metabolomics-Defined Subtypes of Prediabetes and Risk of Cardiovascular-Kidney-Metabolic Outcomes},
  journal = {Diabetes},
  year = {2026},
  doi = {10.2337/db26-0218}
}
Kostenlos starten →